VIVIX
Price
$71.19
Change
-$0.23 (-0.32%)
Updated
Sep 5 closing price
Net Assets
202.84B
VYCBX
Price
$26.58
Change
+$0.14 (+0.53%)
Updated
Sep 4 closing price
Net Assets
1.2B
Interact to see
Advertisement

VIVIX vs VYCBX

Header iconVIVIX vs VYCBX Comparison
Open Charts VIVIX vs VYCBXBanner chart's image
Vanguard Value Index I
Price$71.19
Change-$0.23 (-0.32%)
VolumeN/A
Net Assets202.84B
Voya Corporate Leaders 100 C
Price$26.58
Change+$0.14 (+0.53%)
VolumeN/A
Net Assets1.2B
VIVIX vs VYCBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VIVIX vs. VYCBX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VIVIX is a Buy and VYCBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 203B vs. VYCBX (1.2B). VIVIX pays higher dividends than VYCBX: VIVIX (2.11) vs VYCBX (0.93). VIVIX was incepted earlier than VYCBX: VIVIX (27 years) vs VYCBX (17 years). VYCBX (1.61) is less costly to investors than VIVIX (0.04). VYCBX is a more actively managed with annual turnover of: 29.00 vs. VIVIX (9.00). VYCBX has a lower initial minimum investment than VIVIX: VYCBX (1000) vs VIVIX (5000000). VYCBX annual gain was more profitable for investors over the last year : 9.02 vs. VIVIX (7.74). VIVIX return over 5 years is better than : 70.16 vs. VYCBX (30.80).
VIVIXVYCBXVIVIX / VYCBX
Total Expense Ratio0.041.363%
Annual Report Gross Expense Ratio0.041.612%
Fund Existence27 years17 years-
Gain YTD7.86610.87472%
Front LoadN/AN/A-
Min. Initial Investment50000001000500,000%
Min. Initial Investment IRAN/AN/A-
Net Assets203B1.2B16,959%
Annual Yield % from dividends2.110.93227%
Returns for 1 year7.749.0286%
Returns for 3 years36.6140.4890%
Returns for 5 years70.1630.80228%
Returns for 10 years131.6170.54187%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XRTX0.820.01
+1.85%
XORTX Therapeutics
CPT111.361.02
+0.92%
Camden Property Trust
TMCI7.17N/A
N/A
Treace Medical Concepts
AGIO36.01-0.12
-0.33%
Agios Pharmaceuticals
ZENV1.51-0.05
-3.21%
Zenvia